Skip to main content
. 2024 Sep 21;31(9):5662–5676. doi: 10.3390/curroncol31090420

Figure 3.

Figure 3

Treatment sequencing from 1LM to 2L to 3L treatment regimens during the observation period. Abbreviations: 1LM, first-line maintenance; 2L, second line; 3L, third line; ADC, antibody–drug conjugate; EV, enfortumab vedotin; IO, immuno-oncology.